文献速递肿瘤 PET/CT

儿童淋巴瘤是否需行全身18F-FDG PET/CT?IAEA多中心前瞻性研究

Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study.
PubMed 文献 · J Nucl Med · 2019-01-25

该IAEA多中心前瞻性研究在305例儿童淋巴瘤患者中评估了「眼至大腿」常规视野外病变的发生率及临床影响。共610次扫描显示,8.2%的患者分期PET在常规视野外发现病变,但未改变任何患者的临床分期或治疗决策; interim PET未见常规视野外新发阳性病变。结论认为儿童淋巴瘤分期和中期PET/CT可采用常规视野。

要点

  • 儿童淋巴瘤分期PET/CT中,91.8%患者常规视野外无病变。
  • 8.2%患者常规视野外发现病变,但未改变分期或治疗决策。
  • 中期PET/CT常规视野外无新发阳性病变,可采用常规视野扫描。

核心结论

  • 常规视野外额外病变的识别对儿童淋巴瘤临床分期无影响,对治疗定义影响极小。
  • 分期和中期18F-FDG PET/CT均可采用「眼至大腿」常规视野进行。

研究设计与样本

  • 国际原子能机构(IAEA)多中心前瞻性研究,纳入11个中心儿童淋巴瘤患者。
  • 对305例患者的610次扫描(分期PET和中期PET)进行专家 panel 中心审阅。

主要发现

  • 305例患者中,91.8%的分期PET扫描常规视野外无病变。
  • 8.2%患者的分期PET在常规视野外发现病变(软组织、骨、骨髓和皮肤),但未改变任何患者临床分期或治疗决策。
  • 305次中期PET扫描中,与配对分期PET相比,常规视野外无新发18F-FDG高摄取阳性病变。
  • 仅1例患者(0.3%)中期PET常规视野外出现单发病灶,为分期PET已诊断的股骨原发病灶持续存在。

临床怎么用

  • 儿童淋巴瘤分期和中期18F-FDG PET/CT可仅行「眼至大腿」常规视野扫描,无需全身扫描。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Guidelines recommend true whole-body 18F-FDG PET/CT scans from vertex to toes in pediatric lymphoma patients, although this suggestion has not been validated in large clinical trials. The objective of the study was to evaluate the incidence and clinical impact of lesions outside the "eyes to thighs" regular field of view (R-FOV) in 18F-FDG PET/CT staging (sPET) and interim (iPET) scans in pediatric lymphoma patients. Methods: True whole-body sPET and iPET scans were prospectively obtained in pediatric lymphoma patients (11 worldwide centers). Expert panel central review of sPET and iPET scans were evaluated for lymphoma lesions outside the R-FOV and clinical relevance of these findings. Results: A total of 610 scans were obtained in 305 patients. The sPET scans did not show lesions outside the R-FOV in 91.8% of the patients, whereas in 8.2% patients the sPET scans demonstrated lesions also outside the R-FOV (soft tissue, bone, bone marrow, and skin); however, the presence of these lesions did not change the clinical stage of any patient and did not affect treatment decision. Among the 305 iPET scans, there were no new positive 18F-FDG-avid lesions outside the R-FOV, when compared with their paired sPET scans. A single lesion outside the R-FOV on iPET occurred in 1 patient (0.3%), with the primary lesion diagnosed in the femur on sPET that persisted on iPET. Conclusion: The identification of additional lesions outside the R-FOV (eyes to thighs) using 18F-FDG PET/CT has no impact in the definition of the clinical stage of disease and minimal impact in the treatment definition of patients with pediatric lymphoma. As so, R-FOV for both sPET and iPET scans could be performed.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cerci JJ, Etchebehere EC, Nadel H, et al. Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study. J Nucl Med. 2019. PMID: 30683766. doi:10.2967/jnumed.118.222299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。